Hawk Ridge Capital Management LP acquired a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 287,400 shares of the company's stock, valued at approximately $19,684,000. Henry Schein comprises approximately 0.9% of Hawk Ridge Capital Management LP's portfolio, making the stock its 29th largest position. Hawk Ridge Capital Management LP owned 0.24% of Henry Schein as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. boosted its holdings in Henry Schein by 23.2% in the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after purchasing an additional 201 shares during the period. Humankind Investments LLC boosted its holdings in Henry Schein by 7.4% in the fourth quarter. Humankind Investments LLC now owns 3,057 shares of the company's stock worth $212,000 after purchasing an additional 211 shares during the period. HB Wealth Management LLC boosted its holdings in Henry Schein by 1.5% in the first quarter. HB Wealth Management LLC now owns 15,419 shares of the company's stock worth $1,056,000 after purchasing an additional 226 shares during the period. Allworth Financial LP boosted its holdings in Henry Schein by 24.5% in the first quarter. Allworth Financial LP now owns 1,178 shares of the company's stock worth $78,000 after purchasing an additional 232 shares during the period. Finally, Teachers Retirement System of The State of Kentucky boosted its holdings in Henry Schein by 2.5% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 9,619 shares of the company's stock worth $659,000 after purchasing an additional 238 shares during the period. 96.62% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on HSIC shares. Evercore ISI raised shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price objective for the company in a report on Tuesday, August 26th. Robert W. Baird reaffirmed a "neutral" rating and issued a $72.00 price objective (down previously from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Stifel Nicolaus reaffirmed a "hold" rating and issued a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a report on Friday, July 25th. JPMorgan Chase & Co. decreased their price objective on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a report on Thursday, August 7th. Finally, Wall Street Zen downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Sunday. Five investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $76.67.
Check Out Our Latest Report on Henry Schein
Henry Schein Price Performance
HSIC traded down $1.69 on Monday, reaching $67.74. The company had a trading volume of 1,512,871 shares, compared to its average volume of 1,751,953. The company has a fifty day moving average of $69.92 and a 200-day moving average of $69.68. The company has a market capitalization of $8.21 billion, a P/E ratio of 21.85, a PEG ratio of 2.29 and a beta of 0.86. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49.
Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). The company had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business's quarterly revenue was up 3.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, equities research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.
Henry Schein Company Profile
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Articles

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.